Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Alx Oncology Holdings Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 69 | 1 | 93 | +25 |
| Shares | 94.3M | 65 | 105.2M | +10.9M (+11.6%) |
| Value | $189.0M | $130 | $217.9M | +$28.9M (+15.3%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Alx Oncology Holdings Inc at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (11)
Institutions that held Alx Oncology Holdings Inc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 2,000,000 | $4.01M |
| Squadron Capital Management LLC | 1,460,000 | $2.93M |
| Qube Research & Technologies Ltd | 107,647 | $215.8K |
| Bank of Nova Scotia | 105,858 | $212.2K |
| Jane Street Group, LLC | 95,101 | $190.7K |
| Brevan Howard Capital Management LP | 79,389 | $159.2K |
| Omers Administration Corp | 75,000 | $150.4K |
| Point72 Asset Management, L.P. | 41,095 | $82.4K |
| Nine Masts Capital Ltd | 20,623 | $41.3K |
| Two Sigma Securities, LLC | 10,993 | $22.0K |
| Optiver Holding B.V. | 27 | $54 |
Not filed for Q2 2026 yet (1)
Institutions that held Alx Oncology Holdings Inc at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 65 | $130 |